Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 region

This publication has 16 references indexed in Scilit:

• Peptide and pseudopeptide analogues of cholecystokinin, chemical modifications of the met28-gly29 region
  Tetrahedron, 1988
• Synthesis and biological activities of pseudopeptide analogs of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds
  Journal of Medicinal Chemistry, 1987
• Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice
  European Journal of Pharmacology, 1986
• [3H] BOC [NLE28,31]CCK27−33, a new highly labelle ligand for CCK receptors: Binding on brain and on pancreas
  Life Sciences, 1985
• Products of cholecystokinin (CCK)-octapeptide proteolysis interact with central CCK receptors
  Neuroscience Letters, 1985
• Behavioral and neurophysiological evidence for a facilatory interaction between co-existing transmitters: cholecystokinin and dopamine
  Neurochemistry International, 1984
• Pathway of inactivation of cholecystokinin octapeptide (CCK-8) by synaptosomal fractions
  Neurochemistry International, 1983
• Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection
  European Journal of Pharmacology, 1980
• Evidence for coexistence of dopamine and CCK in meso-limbic neurones
  Nature, 1980
• A new and rapid method for the clinical determination of α-amylase activities in human serum and urine. optimal conditions
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1969